日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK

英国接受司美格鲁肽治疗的非2型糖尿病心血管疾病患者的预期寿命延长

Van Sloten, Thomas; Hageman, Steven H J; Westerink, Jan; Capucci, Silvia; Diogo da Rocha Fernandes, João; Holloway, Sara; Pijper, Andrew; Tikhonovsky, Natalie; Emerson, Scott; Lincoff, A Michael; Plutzky, Jorge; Lingvay, Ildiko

Sex Differences in Statin Intolerance: Insights From the CLEAR Outcomes Trial

他汀类药物不耐受的性别差异:来自 CLEAR Outcomes 试验的启示

Naderi, Sahar; Brennan, Danielle; Li, Na; Lincoff, A Michael; Nicholls, Stephen J; Nissen, Steven E; Plutzky, Jorge; Powell, Heather A; Robinson, Paula; Cho, Leslie

Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design

调查美国难治性高血压人群中内源性高皮质醇症的患病率:MOMENTUM 研究的理论基础和设计

Plutzky, Jorge; Taub, Pam R; Bhatt, Deepak L; Al Dhaybi, Omar; Aroda, Vanita R; Basile, Jan N; Bloch, Michael J; Budoff, Matthew; Busch, Robert S; Buse, John B; Cheung, Dianne; Christofides, Elena A; DeFronzo, Ralph A; Galindo, Rodolfo J; Handelsman, Yehuda; Laffin, Luke; Parker, John C; Rader, Florian; Rosenstock, Julio; Sloan, Lance A; Tudor, Iulia Cristina; Einhorn, Daniel

Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis

PREVENT 与汇总队列方程在评估类风湿性关节炎患者动脉粥样硬化性心血管疾病风险方面的比较

Usiskin, Ilana M; Weber, Brittany N; Qi, Ying; Zhong, Katherine; Jeffway, Mary; Weinblatt, Michael E; Shadick, Nancy; Plutzky, Jorge; Liao, Katherine P

Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis

贝培多酸预防肥胖人群心血管事件:CLEAR Outcomes 子集分析

Bays, Harold E; Bloedon, LeAnne; Brennan, Danielle; Lei, Lei; Lincoff, A Michael; Nicholls, Stephen J; Plutzky, Jorge; Powell, Heather A; Nissen, Steven E

The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes

在超重或肥胖且患有已确诊心血管疾病但无糖尿病的人群中,使用司美格鲁肽治疗所需的复合人数

Lübker, Christopher; Bhavsar, Jigish; Duque do Vale, Ruben; Emerson, Scott S; Nørtoft, Emil; Plutzky, Jorge; Roberts, Geraint; Tarp, Jens Magelund; Lincoff, A Michael

Transcriptomic signatures of subcutaneous adipose tissue in patients with diabetes and coronary artery disease: a pilot study

糖尿病合并冠状动脉疾病患者皮下脂肪组织的转录组特征:一项初步研究

Doulamis, Ilias P; Pan, Bernard; Tzani, Aspasia; Plutzky, Jorge; Wong, G William; Kilic, Ahmet; Wolf, Risa M

Contemporary treatment patterns of overweight and obesity: insights from the Mass General Brigham health care system

当代超重和肥胖的治疗模式:来自麻省总医院布莱根医疗保健系统的启示

Ostrominski, John W; Wagholikar, Kavishwar B; Olsson, Kelly; Unlu, Ozan; Zelle, David; Kumar, Sanjay; Smith, Austen M; Toliver, Joshua C; Michalak, Wojciech; Fabricatore, Anthony; Hartaigh, Bríain Ó; Baer, Heather J; Cannon, Christopher P; Apovian, Caroline M; Fisher, Naomi D L; Plutzky, Jorge; Scirica, Benjamin M; Blood, Alexander J

Identifying High-Risk Obese Individuals Without Diabetes for GLP-1RA Therapy Using Coronary CTA

利用冠状动脉CTA识别适合接受GLP-1RA治疗的非糖尿病高危肥胖个体

Blair, Camila V; Huck, Daniel; Besser, Stephanie A; Cardoso, Rhanderson; Shiyovich, Arthur; Berman, Adam N; Biery, David W; Weber, Brittany N; Petranovic, Milena; Nasir, Khurram; Hedgire, Sandeep; Plutzky, Jorge; Cannon, Christopher; Di Carli, Marcelo F; Ghoshhajra, Brian B; Trinquart, Ludovic; Blankstein, Ron

Trends in Myocardial Infarction risk by HIV status in two U.S. healthcare systems

美国两个医疗保健系统中按 HIV 感染状况划分的心肌梗死风险趋势

Lea, Alexandra N; Lyass, Asya; Hurley, Leo B; Ehrbar, Rachel Q; Mahoney, Taylor F; Borowsky, Leila H; He, Wei; Plutzky, Jorge; Triant, Virginia A; Silverberg, Michael J